[1] CDC, “Bioterrorism Brokers/Illnesses,” Facilities for Illness Management and Prevention, 15-Could-2019. [Online].
[2] R. C. Maves and C. M. Berjohn, “Zoonotic infections and biowarfare brokers in crucial care: Anthrax, plague, and tularemia,” in Extremely Infectious Illnesses in Crucial Care, Cham: Springer Worldwide Publishing, 2020, pp. 97–118.
[3] J. M. Petersen and M. E. Schriefer, “Tularemia: emergence/re-emergence,” Vet. Res., vol. 36, no. 3, pp. 455–467, 2005.
[4] J. P. Dudley and M. H. Woodford, “Bioweapons, biodiversity, and ecocide: Potential results of organic weapons on organic variety,” Bioscience, vol. 52, no. 7, p. 583, 2002.
[5] Ok. A. Feldman, “Tularemia,” JAVMA, vol. 222, no. 6, pp. 725–730, 2003.
[6] J. Ellis, P. C. F. Oyston, M. Inexperienced, and R. W. Titball, “Tularemia,” Clin. Microbiol. Rev., vol. 15, no. 4, pp. 631–646, 2002.
[7] N. S. Harik, “Tularemia: epidemiology, prognosis, and remedy,” Pediatr. Ann., vol. 42, no. 7, pp. 288–292, 2013.
[8] S. Gürcan, “Epidemiology of tularemia,” Balkan Med. J., vol. 31, no. 1, pp. 3–10, 2014.
[9] T. Kantardjiev et al., “Tularemia outbreak, Bulgaria, 1997-2005,” Emerg. Infect. Dis., vol. 12, no. 4, pp. 678–680, 2006.
[10] H. Akalin, S. Helvaci, and S. Gedikoğlu, “Re-emergence of tularemia in Turkey,” Int. J. Infect. Dis., vol. 13, no. 5, pp. 547–551, 2009.
[11] CDC, “Tularemia,” Facilities for Illness Management and Prevention, 18-Dec-2019. [Online]
[12] U. Muslu, E. Senel, and Y. Karabulut, “Erythema multiforme and erythema nodosum lesions with cervical lymphadenopathy,” Dermatol. Pract. Idea., vol. 7, no. 3, pp. 70–72, 2017.
[13] CDC, “Indicators & signs,” Facilities for Illness Management and Prevention, 18-Dec-2019. [Online]
[14] CDC, “Analysis & remedy,” Facilities for Illness Management and Prevention, 18-Dec-2019. [Online]
[15] P. C. F. Oyston, A. Sjostedt, and R. W. Titball, “Tularaemia: bioterrorism defence renews curiosity in Francisella tularensis,” Nat. Rev. Microbiol., vol. 2, no. 12, pp. 967–978, 2004.
[16] B. Zellner and J. F. Huntley, “Ticks and tularemia: Do we all know what we don’t know?,” Entrance. Cell. Infect. Microbiol., vol. 9, p. 146, 2019.
[17] R. Orenstein, “Bioterrorism and infectious brokers: A brand new dilemma for the twenty first century,” Mayo Clin. Proc., vol. 81, no. 2, p. 269, 2006.
[18] J. V. Hirschmann, “From squirrels to organic weapons: The early historical past of tularemia,” Am. J. Med. Sci., vol. 356, no. 4, pp. 319–328, 2018.
[19] CDC, “Statistics,” Facilities for Illness Management and Prevention, 28-Could-2021. [Online][Accessed: 30-Jul-2022].
[20] D. Ok. Yeni, F. Büyük, A. Ashraf, and M. S. U. D. Shah, “Tularemia: a re-emerging tick-borne infectious illness,” Folia Microbiol. (Praha), vol. 66, no. 1, pp. 1–14, 2021.
[21] R. Dryselius et al., “Massive outbreak of tularaemia, central Sweden, July to September 2019,” Euro Surveill., vol. 24, no. 42, 2019.
[22] L. C. Kinkead and L.-A. H. Allen, “Multifaceted results of Francisella tularensis on human neutrophil operate and lifespan,” Immunol. Rev., vol. 273, no. 1, pp. 266–281, 2016.
